Transforming Clinical Pathways

[...]urine albumin to creatinine ratio is often measured at the point-of-care in a network of clinics. Because of limited data on the quality of this test, Tamika Regnier, BMedSc, and colleagues investigate this aspect using 16 years of analytical quality data. Adil I. Khan, MSc, PhD Adil I. Khan, M...

Full description

Saved in:
Bibliographic Details
Published inArchives of pathology & laboratory medicine (1976) Vol. 144; no. 10; pp. 1164 - 1165
Main Author Khan, Adil I
Format Journal Article
LanguageEnglish
Published Northfield College of American Pathologists 01.10.2020
Subjects
CD44 antigen
Coronaviruses
COVID-19
Creatinine
Evaluation
Health care services accessibility
L-selectin
Management
Medical tests
Pandemics
Patient care planning
Public health administration
Scholarships & fellowships
Zika virus
United States
Australia
United States > US
Pennsylvania
Online AccessGet full text

Cover

More Information
Summary:[...]urine albumin to creatinine ratio is often measured at the point-of-care in a network of clinics. Because of limited data on the quality of this test, Tamika Regnier, BMedSc, and colleagues investigate this aspect using 16 years of analytical quality data. Adil I. Khan, MSc, PhD Adil I. Khan, MSc, PhD, is an associate professor of pathology at the Lewis Katz School of Medicine, Temple University, in Philadelphia, Pennsylvania, and the medical director for point-of-care testing and clinical chemistry for the Temple University Health System. Dr Khan then pursued a postdoctoral research fellowship at the University of Calgary, Canada, studying the role of L-selectin and CD44 in models of acute inflammation, followed by a postdoctoral clinical chemistry training fellowship at the University of Texas Southwestern Medical Center at Dallas. Since 2006, he has been teaching at Temple University, lecturing to pathology residents, medical students, and students of podiatric medicine.
Bibliography:ObjectType-Article-1
content type line 23
SourceType-Scholarly Journals-1
ISSN:0003-9985
1543-2165
1543-2165
DOI:10.5858/arpa.2020-0438-ED